A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation-Reference-Cited by-同舟云学术

A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation

Published:2019-04-27 Issue:1 Volume:20 Page:
ISSN:1471-2172
Container-title:BMC Immunology
language:en
Short-container-title:BMC Immunol

Author:

Wittenbrink Nicole,Herrmann Sabrina,Blazquez-Navarro Arturo,Bauer Chris,Lindberg Eric,Wolk Kerstin,Sabat Robert,Reinke Petra,Sawitzki Birgit,Thomusch Oliver,Hugo Christian,Babel Nina,Seitz Harald,Or-Guil Michal

Funder

Bundesministerium für Bildung und Forschung

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1186/s12865-019-0291-2.pdf

Reference59 articles.

1. Djamali A, Kaufman DB, Ellis TM, Zhong W, Matas A, Samaniego M. Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant. 2014;14(2):255–71.

2. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the Most recent era. Am J Transplant. 2004;4(3):378–83.

3. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004;4(8):1289–95.